Anti-E alloimmunization in a pregnancy with a low antibody titer
Red blood cell alloimmunization during pregnancy causes hemolytic disease of the fetus and newborn. While alloimmunization in pregnancy is treatable with anti-D antibodies, management with other antibodies has not been studied. A 32-year-old woman had anti-E antibodies detected during pregnancy, but...
Main Authors: | K. Nakanishi, Y. Oishi, T. Miyamoto, E. Nakamura, K. Murakami, M. Ono, A. Nozawa, S. Kitamura, K. Sengoku |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2020-08-01
|
Series: | Clinical and Experimental Obstetrics & Gynecology |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/CEOG/47/4/10.31083/j.ceog.2020.04.4267 |
Similar Items
-
Clinical response to therapeutic plasmapheresis and intravenous immunoglobulin in pregnancies complicated by alloimmunization despite persistently high titers: Report of two cases
by: Nedaa Bahkali, et al.
Published: (2023-11-01) -
Anti-M Alloimmunization: Management and Outcome at a Single Institution
by: Bethany Stetson, et al.
Published: (2017-10-01) -
Kell alloimmunization in pregnancy: Lessons to be learnt
by: Rajeswari Subramaniyan
Published: (2017-01-01) -
Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China
by: Wenxu Pan, et al.
Published: (2023-04-01) -
Hemolytic disease of the fetus and newborn due to multiple alloantibodies in pregnancy
by: Vidushi Gupta, et al.
Published: (2020-01-01)